Xtant Medical Holdings, Inc. Appoints Ronald Berlin as Vice President & Chief Operations Officer
January 11, 2019 at 09:00 am EST
Share
Xtant Medical Holdings, Inc. announced the appointment of Ronald Berlin as Vice President & Chief Operations Officer, effective January 1, 2019. He will report to Michael Mainelli, the company's Interim Chief Executive Officer. He brings over 35 years of operations experience to the company. Most recently, he served as Vice President of Global Operations for CoorsTek Medical. Prior to that role, he held positions of Vice President, Global Strategic Sourcing and Procurement and Vice President, Operations for Integra LifeSciences.
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
XTANT MEDICAL HOLDINGS, INC. 
